Journal article
Heterogeneity within and between physician-diagnosed asthma and/or copd: novelty cohort
HK Reddel, J Vestbo, A Agustí, GP Anderson, AT Bansal, R Beasley, EH Bel, C Janson, B Make, ID Pavord, D Price, E Rapsomaniki, N Karlsson, DK Finch, J Nuevo, A de Giorgio-Miller, M Alacqua, R Hughes, H Müllerová, MG De Verdier
European Respiratory Journal | Published : 2021
Abstract
Background Studies of asthma and chronic obstructive pulmonary disease (COPD) typically focus on these diagnoses separately, limiting understanding of disease mechanisms and treatment options. NOVELTY is a global, 3-year, prospective observational study of patients with asthma and/or COPD from real-world clinical practice. We investigated heterogeneity and overlap by diagnosis and severity in this cohort. Methods Patients with physician-assigned asthma, COPD or both (asthma+COPD) were enrolled, and stratified by diagnosis and severity. Baseline characteristics were reported descriptively by physicianassigned diagnosis and/or severity. Factors associated with physician-assessed severity were ..
View full abstractGrants
Awarded by National Heart, Lung, and Blood Institute
Funding Acknowledgements
The NOVELTY study is funded by AstraZeneca.